Chamomile for Health & Longevity - Quick Reference Sheet

Chamomile for Health & Longevity

Created on 06/20/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Chamomile, a daisy-family flowering plant used for centuries as a calming tea, shows its strongest human evidence for modestly better sleep quality and meaningfully reduced long-standing worry over a few weeks. Early signals exist for blood sugar, menstrual pain, and digestion. Safety is reassuring; aging and cancer claims remain unproven. (Full Review)

Protocol

Standard Tea
1–4 g dried flowers
Steep 5–10 min, 1–4×/day; evening cup for sleep
Standardized Extract (Anxiety)
220–1100 mg/day
~1.2% apigenin, divided doses, escalated over weeks
Isolated Apigenin (Sleep)
~50 mg before bed
Taken 30–60 min before bed
Time to effect
Sleep
30–60 min
Felt acutely after an evening cup
Anxiety
2–4 weeks
Builds gradually with consistent daily use
Digestion
30–60 min
Felt acutely after an evening cup

Benefits

Contraindications
  • Allergy to ragweed, daisies, marigolds, or chrysanthemums
  • History of anaphylaxis
  • Warfarin with poorly controlled INR
  • Surgery within two weeks
  • Pregnancy or breastfeeding
Key Interactions
  • Anticoagulants/antiplatelets (warfarin, aspirin, clopidogrel)
  • Sedatives/CNS depressants (benzodiazepines, zolpidem, opioids, alcohol)
  • OTC sleep aids/antihistamines (diphenhydramine), OTC pain relievers (aspirin, ibuprofen)
  • Cyclosporine and CYP-metabolized drugs
  • Sedating supplements (valerian, melatonin, L-theanine, magnesium)
  • Glucose-lowering supplements (berberine, alpha-lipoic acid, cinnamon extract)
  • Hormone therapy or estrogen-active agents

Risk & Side Effects

  • High: Allergic reactions
  • Medium: Drowsiness and sedation; gastrointestinal upset
  • Low: Increased bleeding risk with anticoagulants
  • Speculative: Hormonal effects from apigenin; pregnancy-related concerns

Monitoring

Marker Target Why
INR Per anticoagulant target (often 2.0–3.0) Detects additive blood-thinning effect in warfarin users
Fasting blood glucose 75–85 mg/dL Tracks any glucose-lowering effect
HbA1c < 5.4% Reflects average blood sugar over ~3 months
hs-CRP < 1.0 mg/L Gauges any systemic anti-inflammatory effect

Cadence: INR within 1–2 weeks of starting, then periodically; glucose and HbA1c every 3–6 months

Qualitative Assessment

  • Sleep quality, including ease of falling asleep and number of nighttime awakenings
  • Daytime energy and absence of next-day grogginess
  • Subjective anxiety and sense of calm over a 2–4 week period
  • Digestive comfort after meals
  • Absence of allergic symptoms (rash, itching, nasal symptoms)